Bioequivalence of Exib 120 mg vs Arcoxia 120 mg in Healthy Volunteers

Phase 1, randomised, open-label trial of etoricoxib in osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis (AS) and 1 more (2 arms), sponsored by Darnitsa. Primary endpoints: Maximum Plasma Concentration at 72 hours and Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Concentration at 72 hours. Started Feb 2021; status: completed.